Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Solar energy converter with improved photovoltaic efficiency, frequency conversion and thermal management permitting super highly concentrated collection
Reliable event broadcaster with multiplexing and bandwidth control functions
Method for preparing an organic film at the surface of solid support under non-electrochemical conditions, solid support thus obtained and preparation kit
Providing policy-based operating system services in an operating system on a computing system
Methods of measuring cell viability in tissue engineered products
Method and system for utilizing native ethernet as a virtual memory interconnect
Wafer level package and fabrication method
  Randomly Featured Patents
Apparatus for electric discharge machining of holes
Method for producing cobalt-protein complex
Fake fishing bait
Fused-ring derivative and medical application of same
Nut cracking apparatus
Plasma processing method and apparatus
Shoe sole
Adapter for the aspiration nozzle of an automatic analytical instrument
Method and system for automatic determination of ammunition type, and the use thereof
Variable transfer rate control coding apparatus